Search Results - Ignacio Aristegui
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain by Enrique Casado, Jose Rosas, Carlos Rubio-Terres, Dario Rubio-Rodriguez, Mitra Boolell, Ignacio Aristegui
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book